Hacker News new | ask | show | jobs
by mlyle 2302 days ago
I agree that this is likely true, but it's worth noting the big caveat: sensitivity of the tests are poor, particularly (to an unknown extent) in people with mild disease. Until we have good serological antibody testing it's going to be difficult to quantify.